Table 3.
Aphasia | Motor deficit | Dysarthria | Dysphagia | Sex | NIHSS | mRS d90 | Age | ||
---|---|---|---|---|---|---|---|---|---|
HLA-DR | Inclusion | 0.405 | 0.979 | 0.548 | 0.757 | 0.606 | 0.409 | 0.052 | 0.249 |
Lowest | 0.987 | 0.436 | 0.959 | 0.173 | 0.340 | 0.099 | 0.030 | 0.069 | |
IL-6 | Inclusion | 0.410 | 0.478 | 0.912 | 0.739 | 0.824 | 0.005 | 0.252 | 0.001 |
Highest | 0.369 | 0.281 | 0.983 | 0.438 | 0.884 | 0.005 | 0.015 | 0.030 | |
IL-8 | Inclusion | 0.443 | 0.050 | 0.640 | 0.552 | 0.803 | 0.073 | 0.226 | 0.339 |
Highest | 0.633 | 0.393 | 0.386 | 0.467 | 0.597 | 0.331 | 0.683 | 0.566 | |
IL-10 | Inclusion | 0.416 | 0.468 | 0.136 | 0.611 | 0.564 | 0.916 | 0.248 | 0.460 |
Highest | 0.247 | 0.360 | 0.257 | 0.727 | 0.989 | 0.683 | 0.587 | 0.236 | |
LBP | Inclusion | 0.086 | 0.364 | 0.958 | 0.660 | 0.227 | 0.291 | 0.952 | 0.148 |
Highest | 0.857 | 0.861 | 0.442 | 0.353 | 0.621 | 0.062 | 0.637 | 0.152 | |
MPproANP | Inclusion | 0.486 | 0.640 | 0.012 | 0.029 | 0.914 | 0.163 | 0.654 | 0.005 |
Highest | 0.521 | 0.287 | 0.047 | 0.005 | 0.926 | 0.068 | 0.911 | 0.005 | |
MPproADM | Inclusion | 0.001 | 0.320 | 0.310 | 0.915 | 0.296 | 0.241 | 0.264 | < 0.001 |
Highest | 0.351 | 0.209 | 0.618 | 0.979 | 0.547 | 0.158 | 0.043 | 0.001 | |
CTproET | Inclusion | 0.398 | 0.323 | 0.613 | 0.994 | 0.962 | 0.160 | 0.344 | 0.018 |
Highest | 0.015 | 0.330 | 0.893 | 0.888 | 0.933 | 0.092 | 0.169 | 0.039 | |
Copeptin us | Inclusion | 0.720 | 0.455 | 0.548 | 0.436 | 0.357 | 0.768 | 0.006 | 0.540 |
Highest | 0.335 | 0.910 | 0.354 | 0.441 | 0.115 | 0.918 | 0.144 | 0.298 | |
PCT us | Inclusion | 0.643 | 0.381 | 0.007 | 0.736 | 0.286 | 0.254 | 0.962 | 0.975 |
Highest | 0.855 | 0.560 | 0.056 | 0.908 | 0.362 | 0.634 | 0.230 | 0.711 |
Values given are two-sided p-values obtained by a students' t-test; Bold text denotes significant associations; HLA-DR, Human leukocyte antigen expression on monocytes; IL-6, IL-8, IL-10, three interleukins; LBP, lipopolysaccharide-binding protein; MRproANP, mid-regional pro atrial natriuretic peptide; MRproADM, mid-regional pro adrenomedullin; CTproET, C-terminal pro endothelin; CPus, ultrasensitive copeptin; PCTus, ultrasensitive procalcitonin.